Consider increased clinical or laboratory monitoring for medications that have a narrow therapeutic index or that require clinical monitoring Use in Specific Populations Pregnancy: Available data with semaglutide use in pregnant women are not sufficient to determine a drug associated risk for major birth defects, miscarriage, or other adverse maternal or fetal outcomes
Freezing causes ice crystal formation that physically tears apart the peptide structure
Gallbladder problems have happened in some people who use Mounjaro injection
This phenomenon occurs through several metabolic mechanisms: Increased breakdown of purines : When the body metabolises fat and muscle tissue during weight loss, purines (compounds found in body tissues) are broken down, producing uric acid as a by-product Ketone body production : Rapid weight loss, particularly with very low-calorie diets, leads to ketone production, which competes with uric acid for excretion by the kidneys Reduced renal clearance : Ketones and other metabolic by-products can temporarily impair the kidneys' ability to excrete uric acid efficiently Dehydration : Weight loss programmes may involve reduced fluid intake or increased fluid loss, concentrating uric acid in the blood The rate of weight loss appears to be a critical factor
However, the lower dose of semaglutide used and a focus on patient-reported outcomes rather than on cardiovascular events are limitations of STEP-HFpEF DM
Some users find the tablets difficult to swallow or report an unpleasant aftertaste